Market closed·Syncing…
Market closed · Close · 19 Nov

Tarsons Products Limited TARSONSshare price and chart

Tarsons Products closed at ₹303.70 on 19 November 2026, up 1.84% on the day. The 52-week range is ₹164.45 to ₹375.00.

₹303.70The price one share last traded at, in rupees.+1.84% · ₹5.49
52-wk low ₹16466% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹375

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on TARSONS

Real prices, every charge counted. Pick one or write your own.
What Tarsons Products Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Tarsons Products makes plastic labware, 100% of its turnover, from seven plants, selling mainly to contract research organisations and the pharmaceutical sector, with the rest from a range of other sectors, in 28 states and 40 countries. Exports are 31% of turnover.

1
1Sector

Healthcare Equipment & Supplies

2
2What it sells

Plastic labware

3
3Who buys it

CROs, pharmaceutical companies

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
44.9Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
46.4%Near average
today 46.4%20d avg 51.5%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 4.4%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.+15.8%1 monthHow much the share price has changed over the period.+1.2%3 monthsHow much the share price has changed over the period.▼ 11.5%1 yearHow much the share price has changed over the period.+26.0%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.42.7%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹1,616 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.215.4xlast 4 quarters, to Sept 2026Return on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.2.3%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.2.55xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.4.5%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.14.1xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.61xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-1.7%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Medical Equipment & Supplies · 16 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.215.39vs 28.23 median
Cheapest: GKB 6.05Priciest: TARSONS 215.39
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.1.61%vs 7.06% median
Lowest: MHHL -4.14%Highest: AVIENCE 17.16%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.20.84%vs 17.5% median
Lowest: FABTECH -24.2%Highest: NURECA 55.08%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 12 Nov 2026), sales rose 20.8% from a year earlier to ₹124 cr and profit turned to a loss of ₹0.3 cr from ₹3.3 cr a year earlier.

Going well
  • Sales grew 3 years running (₹283 cr in FY23 to ₹422 cr in FY26).
  • Cash from operations was at least the reported profit in each of FY24, FY25, FY26.
Worth watching
  • Profit fell 3 years running (₹80.7 cr in FY23 to ₹14.3 cr in FY26).
  • Operating margin fell from 45.8% in FY23 to 27.9% in FY26.
  • Profit before interest covered interest 2.0 times in FY26 (₹22 cr of interest).
  • Return on equity stayed under 10% from FY24 to FY26 (highest 7.2%).
Also changed
  • Foreign institutions cut their holding by 8.6 points over 5 quarters (9.14% to 0.55%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 19 results, the share rose on 4 and fell on 15, and moved by 3% or more on 14.

+13%
-13%
Q1 FY23Q1 FY24Q1 FY25Q1 FY26Q2 FY27

Q2 FY27: results filed 12 Nov 2026. The share went from its close on 11 Nov 2026 to its close on 13 Nov 2026 -2.97%.

Dividend historyCash the company has paid per share, year by year.

₹659 in 2024
Paid 1 of 1 yrs
what 2024's payouts come to on ₹1 lakh at today's price · nothing declared in the last twelve months
What each year paid, on ₹1 lakh
659
24

2024 paid ₹2.00 per share, about ₹659 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
-14.6%a year, over 3 years
1 yr
+35.7%
3 yr
-14.6%

Held for 3 years this compounded at -14.6% a year. The last twelve months were up +35.7%. Price only, before dividends.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
47.3%promoter holding, as of 2026-09-30+0.0 pts since 2021
Promoter share since listing
2021-1147.3% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
47.3%
51.5%
Promoter47.3%Foreign (FII)0.6%Domestic (DII)0.6%Public & others51.5%
Who is buying, who is leavingJun 25 to Sep 26
Promoter47.3%steady
Foreign (FII)0.6%-8.6 pts
Domestic (DII)0.6%+0.6 pts

Each line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Analysts/Institutional Investor Meet/Con. Call Updates19-Nov-2026

Tarsons Products Limited has informed the Exchange about Transcript

Copy of Newspaper Publication13-Nov-2026

Tarsons Products Limited has informed the Exchange about Copy of Newspaper Publication

Analysts/Institutional Investor Meet/Con. Call Updates13-Nov-2026

Tarsons Products Limited has informed the Exchange about Link of Recording

Analysts/Institutional Investor Meet/Con. Call Updates13-Nov-2026

Tarsons Products Limited has informed the Exchange about Presentation

Analysts/Institutional Investor Meet/Con. Call Updates12-Nov-2026

Tarsons Products Limited has informed the Exchange about Schedule of meet

General Updates12-Nov-2026

Tarsons Products Limited has informed the Exchange about General Updates

Outcome of Board Meeting12-Nov-2026

Tarsons Products Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Analysts/Institutional Investor Meet/Con. Call Updates04-Nov-2026

Tarsons Products Limited has informed the Exchange about Schedule of meet

Certificate under SEBI (Depositories and Participants) Regulations, 201809-Oct-2026

Tarsons Products Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Change in Management28-Sep-2026

Tarsons Products Limited has informed the Exchange about change in Management

Shareholders meeting28-Sep-2026

Tarsons Products Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.

Trading Window24-Sep-2026

Tarsons Products Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Analysts/Institutional Investor Meet/Con. Call Updates24-Sep-2026

Tarsons Products Limited has informed the Exchange about Schedule of meet

Shareholders meeting24-Sep-2026

Tarsons Products Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026

Spurt in Volume21-Sep-2026

Significant increase in volume has been observed in Tarsons Products Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Tarsons Products Limited has submitted their response.

Backtest idea · TARSONSMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on TARSONS
Backtest idea · TARSONSLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on TARSONS
Backtest idea · TARSONSSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on TARSONS
Your own ideaWrite a rule for TARSONS in plain English“Buy TARSONS when …”
Start writing
Buy the dip on TARSONSBuy when RSI(14) drops below 30
52-week high breakout on TARSONSBuy when closes at a 52-week high
Golden cross on TARSONSBuy when 50-day EMA crosses above 200-day
Stochastic oversold on TARSONSBuy when stochastic %K drops below 20
Pullback in an uptrend on TARSONSBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹1,616 cr
Larger than 88% of 16 peers
sector middle ₹429 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
215.4x
Highest of 12 peers
sector middle 28.2x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
2.5x
Higher than 57% of 14 peers
sector middle 2.3x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
2.3%
Lower than 80% of 5 peers
sector middle 9.1%
FY23 14.2%FY26 2.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
4.5%
Lower than 83% of 12 peers
sector middle 12.3%
FY23 16.6%FY26 4.5%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.61
Higher than 79% of 14 peers
sector middle 0.15
FY23 0.19FY26 0.60
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 38% of 16 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+20.8%
Higher than 56% of 9 peers
sector middle +17.5%
FY24 4.7%FY26 7.7%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Revenue and profit, year by yearSales and net profit by financial year or by quarter.

Sales and net profit
FY23FY24FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.27.9%FY26Profit YoYHow much net profit grew in the latest quarter against the same quarter a year earlier.▼ 110.4%latest quarterSalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹423 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹14 CrFY26

Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.

FY26

In FY26, of every ₹100 of sales it kept ₹3.4 as profit. Other income added ₹5.7.

Where it wentPer ₹100 of sales
Running costs₹72.1Depreciation₹22.8Interest₹5.3Tax₹1.8Profit₹3.4
Profit per ₹100, year by year
FY23FY26

How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.

Compounded a year
3 years5 yearsLatest qtr
Sales+14.3%-+20.8%
Profit▼ 43.8%-▼ 110.4%
3 and 5 years are compounded a year across full financial years. The latest quarter is against the same quarter a year earlier.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹2 Cr, after ₹126 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹118 Cr
Investing-₹130 Cr
Lenders and shareholders+₹9 Cr
Net change in cash-₹2 Cr
Operating cash per ₹100 of profit
₹94FY23₹241FY24₹384FY25₹827FY26
₹100 or more means the reported profit arrived as cash.

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY23FY24FY25FY26
Sales growthSales in this financial year against the previous one.·4.7%32.4%7.7%
Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.45.8%33.7%28.2%27.9%
Net marginOf every ₹100 of sales in the year, how much was left as profit after everything.28.5%14.4%7.6%3.4%
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.14.2%7.2%4.8%2.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.16.6%9.2%7.0%4.5%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.19x0.42x0.52x0.60x
Interest coverHow many times the company's profit before interest could pay its interest bill.25.2x7.0x3.3x2.0x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · TARSONSStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on TARSONS
Backtest idea · TARSONSPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on TARSONS
Backtest idea · TARSONSBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on TARSONS
Backtest idea · TARSONS52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on TARSONS
Backtest idea · TARSONSGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on TARSONS
MACD momentum on TARSONSBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on TARSONSBuy when closes below the lower Bollinger band
Supertrend rider on TARSONSBuy when supertrend turns up
Buy the dip on TARSONSBuy when RSI(14) drops below 30
52-week high breakout on TARSONSBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Medical Equipment & Supplies
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
MOLBIO
Molbio Diagnostics Limited
17,590 cr-12.2x--0.22--0.00%
POLYMED
Poly Medicure Limited
16,933 cr53.2x5.2x10.8%13.7%0.1214.8%+30.8%0.21%
TARSONS
Tarsons Products Limited
1,616 cr215.4x2.5x2.3%4.5%0.611.6%+20.8%0.00%
FISCHER
Fischer Medical Ventures Limited
1,496 cr87.9x3.2x8.1%11.5%0.114.3%+24.5%0.22%
LAXMIDENTL
Laxmi Dental Limited
1,060 cr32.7x4.0x12.8%13.1%0.0011.0%+10.0%0.00%
QLINE
Q-Line Biotech Limited
952 cr12.8x2.0x-19.5%0.2715.4%-0.00%
DENTALKART
Vasa Denticity Limited
840 cr69.7x4.4x-9.1%0.003.8%-0.00%
FABTECH
Fabtech Technologies Limited
593 cr15.7x1.4x9.1%11.3%0.079.2%-24.2%0.45%
OSELDEVICE
Osel Devices Limited
527 cr23.8x2.3x-23.9%0.649.5%-0.34%
QMSMEDI
QMS Medical Allied Services Limited
331 cr-3.6x--0.86--0.29%
NURECA
Nureca Limited
285 cr60.7x1.5x1.1%3.3%0.012.7%+55.1%0.00%
APRAMEYA
Aprameya Engineering Limited
238 cr-------0.00%
MADHAVBAUG
Vaidya Sane Ayurved Laboratories Limited
162 cr41.3x2.3x-16.9%0.183.4%+17.5%0.00%
AVIENCE
Avience Biomedicals Limited
138 cr12.2x2.2x-23.2%0.4417.2%-0.00%
MHHL
Mohini Health & Hygiene Limited
49 cr-0.5x--9.9%1.62-4.1%+50.2%0.00%
GKB
GKB Ophthalmics Limited
30 cr6.0x----3.2%+8.5%0.00%
GML
Galaxy Medicare Limited
26 cr8.7x0.6x-11.2%0.107.1%+7.8%4.15%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-16.8
-1.7
-12.8
+32.1
-4.8
+27.9
+17.4
+5.4
-3.4
-9.2
+4.4
·
+30.2%
11m
2025
-7.5
-18.5
-0.8
+19.9
+4.1
+5.1
-7.6
-14.7
-2.1
-5.3
-22.0
+3.5
-42.2%
2024
-8.2
-3.5
-15.8
+16.7
-9.8
+20.6
+3.3
-12.4
-1.9
-8.3
+3.2
-3.8
-23.4%
2023
-0.3
-14.3
-10.4
+6.3
-1.2
+7.8
-0.5
-14.4
+2.5
-10.8
-3.4
+16.3
-24.1%
2022
+9.0
-15.3
+18.0
-1.1
+4.3
-1.4
+14.5
-6.1
+6.1
-4.6
-10.5
-0.3
+7.7%
2021
·
·
·
·
·
·
·
·
·
·
·
-7.5
-7.5%
1m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-08-14NK SECURITIES RESEARCH PRIVATE LIMITED · bulkSELL3,74,087₹351.18₹13.14 Cr
2026-08-14NK SECURITIES RESEARCH PRIVATE LIMITED · bulkBUY3,74,087₹350.87₹13.13 Cr
2026-08-14JUNOMONETA FINSOL PRIVATE LIMITED · bulkSELL3,27,650₹351.12₹11.50 Cr
2026-08-14JUNOMONETA FINSOL PRIVATE LIMITED · bulkBUY3,25,555₹350.74₹11.42 Cr
2026-08-14MICROCURVES TRADING PRIVATE LIMITED · bulkBUY2,84,512₹356.75₹10.15 Cr
2026-08-14MICROCURVES TRADING PRIVATE LIMITED · bulkSELL2,84,512₹357.03₹10.16 Cr
2026-07-21NK SECURITIES RESEARCH PRIVATE LIMITED · bulkSELL3,50,036₹318.86₹11.16 Cr
2026-07-21NK SECURITIES RESEARCH PRIVATE LIMITED · bulkBUY3,50,036₹318.63₹11.15 Cr

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test TARSONS. “Buy TARSONS when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free